Update Alert 5: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.

Mackey, Katherine; Kansagara, Devan; Vela, Kathryn

Mackey, Katherine; Kansagara, Devan; Vela, Kathryn.

Mackey K; VA Portland Health Care System, Portland, Oregon (K.M., D.K., K.V.).
Kansagara D; VA Portland Health Care System, Portland, Oregon (K.M., D.K., K.V.).
Vela K; VA Portland Health Care System, Portland, Oregon (K.M., D.K., K.V.).

Ann Intern Med ; 173(12): 167-168, 2020 12 15.

Article in English | MEDLINE | ID: covidwho-2110791

Subject(s)

Angiotensin Receptor Antagonists; COVID-19; Adult; Angiotensin Receptor Antagonists/adverse effects; Angiotensin-Converting Enzyme Inhibitors/adverse effects; Angiotensins; Humans; Renin-Angiotensin System; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Angiotensin Receptor Antagonists / COVID-19 Type of study: Experimental Studies / Prognostic study Limits: Adult / Humans Language: English Journal: Ann Intern Med Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google